News Author: Jennifer Shepphird Publish date: December 29, 2015
Key clinical point: Most patients with chronic myeloid leukemia require long-term tyrosine kinase inhibitor (TKI) therapy, and cardiovascular effe...
News Author: Jennifer Shepphird Publish date: December 23, 2015
News Author: Jennifer Shepphird Publish date: December 18, 2015
Key clinical point: Maintenance therapy with tumor-treating fields (TTFields) plus temozolomide resulted in longer survival, compared with temozol...
News Author: Jennifer Shepphird Publish date: December 14, 2015
Key clinical point: Single-nucleotide polymorphisms rs12422149 and rs1077858 in the SLCO2B1 gene were associated with time to progression and over...
News Author: Jennifer Shepphird Publish date: December 14, 2015
Patients with acute myeloid leukemia (AML) who are in remission but with minimal residual disease (MRD) have outcomes similar to those of patients wit...
News Author: Jennifer Shepphird Publish date: December 7, 2015
Key clinical point: Patients with time to treatment initiation (TTI) greater than 46-52 days had increased risk of mortality, with greatest risk i...
News Author: Jennifer Shepphird Publish date: December 7, 2015
Key clinical point: Patients who underwent ADT for prostate cancer had significantly increased risk of future Alzheimer’s disease diagnosis. Major ...
News Author: Jennifer Shepphird Publish date: December 7, 2015
Key clinical point: High risk of breast cancer based on specific prediction models was associated with favorable tumor prognosticators and reduced...
News Author: Jennifer Shepphird Publish date: December 3, 2015
Key clinical point: Stereotactic body radiotherapy (SBRT) and radiofrequency ablation (RFA) both achieved good local control for small hepatocellu...
News Author: Jennifer Shepphird Publish date: December 3, 2015
Key clinical point: Addition of lapatinib to capecitabine and oxaliplatin as first-line treatment for HER2-positive advanced gastroesophageal aden...
News Author: Jennifer Shepphird Publish date: November 23, 2015
Key clinical point: Alectinib, an oral, small molecule inhibitor of ALK, showed promising clinical activity in crizotinib-refractory patients with ...
News Author: Jennifer Shepphird Publish date: November 23, 2015
Key clinical point: Adjuvant lapatinib and trastuzumab resulted in similar disease-free survival, compared with trastuzumab alone in early HER2-po...
News Author: Jennifer Shepphird Publish date: November 20, 2015
Key clinical point: Two separate studies demonstrated that survivors of childhood, adolescent, and young adult cancers face high risk of long-term...
News Author: Jennifer Shepphird Publish date: November 18, 2015
Key clinical point: Children and adolescents with cancer have a significantly higher rate of germline mutations in cancer predisposition genes com...
News Author: Jennifer Shepphird Publish date: November 12, 2015
Key clinical point: Patients with head and neck cancer have a significantly higher suicide rate than the general population.
Major finding: The st...
